Main > ONCOLOGY (**) > Lymphoma>NHL>T-Cell>PTCL R/R * > Treatment > USA. S. Brand Pralatrexate Inj.

---

USA. S. Brand Pralatrexate Inj.'s subsections
(*) USA Approval Date: 2009. 09.24.
Company
Folate Analogue Metabolic Inhibitor
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 6
Patent>UpDate: 2016. 10.11.
Patent>USA Expiration: 2025. 11.24.
TradeMark
TradeMark Web-Site
WW Market (Ex CA; USA) Rights:

USA. S. Brand Pralatrexate Inj.'s products
This section has no products